Anebulo Pharmaceuticals Inc. (ANEB)
$0.36
$0.04
(13.97%)
As on 04-Sep-2026 09:30EDT
Market cap
$15 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
1.6
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.7 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-6.5
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-0.2
-
Face value
--
-
Shares outstanding
40,784,731
5 Years Aggregate
CFO
$-25.01 Mln
EBITDA
$-26.00 Mln
Net Profit
$-79.25 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Anebulo Pharmaceuticals (ANEB)
| -64.5 | 8.8 | -4.3 | -85.4 | -48.7 | -44.4 | -- |
|
BSE Sensex*
| -10.1 | -3.6 | 2.5 | -5.7 | 4.9 | 5.5 | 10.1 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Anebulo Pharmaceuticals (ANEB)
| -39.9 | -30.4 | -0.2 | -60.6 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Anebulo Pharmaceuticals (ANEB)
|
0.4 | 14.6 | 0.0 | -8.0 | -- | -81.4 | -- | 1.6 |
| 86.3 | 12,161.6 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.2 | |
| 270.6 | 17,746.8 | 1,054.4 | 755.9 | 5.7 | -- | 20.9 | 10.5 | |
| 72.7 | 10,109.8 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.5 | |
| 59.0 | 14,621.6 | 2,435.9 | 860.6 | 31.0 | 43 | 18.6 | 7.9 | |
| 110.2 | 12,506.3 | 1,663.7 | 413.6 | 36.3 | 430 | 32.3 | 86.7 | |
| 358.2 | 10,603.5 | 440.5 | 241.5 | 33.4 | 18.7 | 44.9 | 8.1 | |
| 541.1 | 12,501.2 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 23.9 | |
| 591.3 | 16,503.9 | 2,782.3 | 491.5 | 21.1 | 110.1 | 34.7 | 38.2 | |
| 124.0 | 9,808.7 | 0.0 | -450.1 | -- | -44.6 | -- | 8.4 |
Shareholding Pattern
View DetailsAbout Anebulo Pharmaceuticals (ANEB)
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The company's... lead product candidate is the selonabant, a small-molecule antagonist of cannabinoid binding receptor type-1(CB1), which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Lakeway, Texas. Read more
-
Founder & Chairman
Dr. Joseph F. Lawler M.D., Ph.D.
-
Founder & Chairman
Dr. Joseph F. Lawler M.D., Ph.D.
-
Headquarters
Lakeway, TX
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Anebulo Pharmaceuticals (ANEB)
What is the current share price of Anebulo Pharmaceuticals Inc (ANEB) Today?
The share price of Anebulo Pharmaceuticals Inc (ANEB) is $0.36 (NASDAQ) as of 04-Sep-2026 09:30 EDT. Anebulo Pharmaceuticals Inc (ANEB) has given a return of -48.71% in the last 3 years.
What is the current PB & PE ratio of Anebulo Pharmaceuticals Inc (ANEB)?
Since, TTM earnings of Anebulo Pharmaceuticals Inc (ANEB) is negative, P/E ratio is not available.
The P/B ratio of Anebulo Pharmaceuticals Inc (ANEB) is 1.62 times as on 04-Sep-2026, a 70 discount to its peers’ median range of 5.33 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-6.97 |
5.07 |
2024 |
-8.59 |
18.49 |
2023 |
-5.36 |
5.94 |
2023 |
-5.02 |
5.56 |
2022 |
-9.23 |
4.18 |
What is the 52 Week High and Low of Anebulo Pharmaceuticals Inc (ANEB)?
The 52-week high and low of Anebulo Pharmaceuticals Inc (ANEB) are Rs 2.85 and Rs 0.07 as of 08-Sep-2026.
What is the market cap of Anebulo Pharmaceuticals Inc (ANEB)?
Anebulo Pharmaceuticals Inc (ANEB) has a market capitalisation of $ 15 Mln as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Anebulo Pharmaceuticals Inc (ANEB)?
Before investing in Anebulo Pharmaceuticals Inc (ANEB), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.